Rational Advisors Inc. Takes $997,000 Position in Ryan Specialty Holdings Inc. (NYSE:RYAN)

Rational Advisors Inc. bought a new stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN) during the 1st quarter, HoldingsChannel.com reports. The fund bought 13,500 shares of the company’s stock, valued at approximately $997,000.

A number of other large investors also recently added to or reduced their stakes in RYAN. GAMMA Investing LLC increased its stake in Ryan Specialty by 21.8% in the 1st quarter. GAMMA Investing LLC now owns 2,101 shares of the company’s stock worth $155,000 after purchasing an additional 376 shares during the period. CIBC Private Wealth Group LLC boosted its position in Ryan Specialty by 6,911.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company’s stock valued at $48,036,000 after buying an additional 774,718 shares during the period. Wealth Enhancement Advisory Services LLC raised its stake in shares of Ryan Specialty by 3.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 12,215 shares of the company’s stock valued at $902,000 after acquiring an additional 460 shares during the last quarter. Jones Financial Companies Lllp grew its stake in shares of Ryan Specialty by 982.1% in the fourth quarter. Jones Financial Companies Lllp now owns 1,450 shares of the company’s stock worth $93,000 after purchasing an additional 1,316 shares during the last quarter. Finally, Natixis Advisors LLC increased its holdings in Ryan Specialty by 95.9% during the 4th quarter. Natixis Advisors LLC now owns 59,649 shares of the company’s stock valued at $3,827,000 after purchasing an additional 29,204 shares during the period. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Insider Activity at Ryan Specialty

In related news, EVP Mark Stephen Katz sold 14,377 shares of the firm’s stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the sale, the executive vice president owned 1,117 shares of the company’s stock, valued at $73,543.28. This trade represents a 92.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David P. Bolger sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total transaction of $354,000.00. Following the completion of the transaction, the director owned 71,467 shares of the company’s stock, valued at approximately $5,059,863.60. The trade was a 6.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 52.21% of the company’s stock.

Analysts Set New Price Targets

RYAN has been the subject of several research analyst reports. The Goldman Sachs Group upgraded Ryan Specialty from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $74.00 to $81.00 in a report on Tuesday, May 13th. Wells Fargo & Company dropped their price target on Ryan Specialty from $65.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday. TD Cowen started coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They issued a “buy” rating and a $89.00 price target on the stock. Morgan Stanley upped their price objective on shares of Ryan Specialty from $78.00 to $80.00 and gave the stock an “overweight” rating in a report on Monday, May 19th. Finally, Barclays cut their target price on shares of Ryan Specialty from $83.00 to $79.00 and set an “overweight” rating on the stock in a research note on Monday, July 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $75.00.

Ryan Specialty Price Performance

RYAN stock opened at $63.84 on Friday. The company has a debt-to-equity ratio of 3.45, a quick ratio of 1.05 and a current ratio of 1.05. The firm has a market capitalization of $16.75 billion, a price-to-earnings ratio of 187.77, a PEG ratio of 1.72 and a beta of 0.66. The firm has a 50 day moving average price of $68.08 and a 200-day moving average price of $68.11. Ryan Specialty Holdings Inc. has a 52-week low of $55.95 and a 52-week high of $77.16.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting analysts’ consensus estimates of $0.39. The firm had revenue of $690.17 million for the quarter, compared to analysts’ expectations of $680.80 million. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The company’s quarterly revenue was up 25.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.35 earnings per share. Equities research analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were paid a dividend of $0.12 per share. The ex-dividend date was Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a yield of 0.75%. Ryan Specialty’s dividend payout ratio is currently 141.18%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.